Ignite Creation Date:
2024-10-25 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06517511
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-14
Brief Title:
Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients Smart Trial
Sponsor:
Organization:
None